CliffBio
small molecule

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyDR REDDYS LABORATORIES INC

Drug detail

Brand nameAMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Active ingredientAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
StrengthEQ 5MG BASE;40MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2011
Marketing statusRX

More from DR REDDYS LABORATORIES INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio